When the Market Sold Off in 2022, This Healthcare ETF Beat the S&P 500 by 16 Percentage Points. With Volatility Back, That History Is Worth Revisiting
Healthcare is not always the most exciting sector to own, and the companies in it grind it out, quarter after quarter, raise dividends quietly, and generally do not produce the kind of explosive returns that technology stocks have delivered in the best years of the past decade.
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
Launched on December 16, 1998, the State Street Health Care Select Sector SPDR ETF ETF (XLV) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.
XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500
Healthcare isn't going anywhere. An aging population, chronic disease management, and breakthrough treatments ensure this sector remains essential regardless of market conditions.
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
The State Street Health Care Select Sector SPDR ETF ETF (XLV) was launched on December 16, 1998, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
XLV Vs. BME: Total Return Or Income, Which Healthcare Strategy Wins?
The Health Care sector, lagging in recent years, is positioned for mean reversion and potential outperformance in 2026. XLV offers low-cost, passive exposure to large-cap Health Care, with a 1.4-1.8% yield and a 19.94x forward P/E. BME, an actively managed closed-end fund, provides a 7.51% yield, trades at a -5.97% NAV discount, and distributes mainly long-term capital gains.
December Jobs Data Put Focus on These Sector ETFs & Stocks
December jobs data highlight sector shifts as healthcare and restaurants add jobs, while retail lags. ETFs XLV, EATZ in focus.
6 Major Investment Themes Shaping 2026
The market looks set to maintain momentum into the New Year with investment in AI infrastructure continuing. But several other sectors are positioned for growth as well.
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed exchange traded fund launched on December 16, 1998.
XLV: The Simple Case For Overweighting U.S. Health Care
The H ealth Care Select Sector SPDR is comprised of all the Health Care stocks inside the S&P 500 Index. Its expense ratio is only 0.08% and XLV has $41.2B in AUM. The simple case for overweighting U.S. Health Care is that XLV currently features a unique combination of a low beta, moderate growth, and excellent momentum and sentiment. XLV also offers terrific growth-at-a-reasonable-price features, but only on a forward basis. A GARP analysis based on historical metrics highlights an interesting divide worth watching.
Best-Performing ETFs of November
November muted for markets, but ETFs like SPYM, BWET, WNTR, LITP and OZEM stand out.
XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Way
The Fed has begun to reduce interest rates in the U.S. This decision will incentivize the deployment of funding in the healthcare industry. The top holdings of XLV are profitable firms, with a median expected growth rate of 6.53% in their revenues. The U.S. legislation that mandates drugmakers to lower the selling price of their medicine in the country will only be applied to Medicaid beneficiaries, which has a limited effect.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ETF (XLV) is a passively managed exchange traded fund launched on December 16, 1998.
